Treatment Indications: correction of moderate to deep facial wrinkles and folds (including nasolabial folds, marionette lines, glabellar and forehead rhytides);, volumizing in mid‑ to deep‑layer zones (cheeks, temples, chin);, ; structural contouring of jawline and nasal bridge;, correction of facial asymmetry and moderate to severe volume deficit;, smoothing of deep depressions and scars; achieving a lifting effect via deep‑layer placement
Release form: 1 × 1.1 mL pre‑filled sterile glass syringe
Compound: cross‑linked hyaluronic acid (manufactured with HBCT and GI technologies); lidocaine; phosphate‑buffered saline solution (pH ~7)
Concentration of GC: 24 mg/mL
Lidocaine: 0.3 %
Indications: volumizing and structural contouring in mid‑ to deep dermal and subcutaneous layers;, restoration of lost volume and facial architecture;, smoothing moderate to deep depressions and folds; providing high‑support, long‑lasting volume with enhanced viscoelasticity and minimal migration